Skip to content

The Macro- and Micro-circulation in Coronary Heart Disease

Assessing the macro- and micro-circulation and their relation to cardiovascular events in patients with coronary heart disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12619000450112
Acronym
None
Enrollment
65
Registered
2019-03-19
Start date
2019-06-06
Completion date
2022-01-30
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of this study is to improve our understanding of coronary microvascular disease (small vessel disease in the blood vessels supplying the heart), and to evaluate whether microvascular disease correlates with poor outcomes. We aim to measure blood flow in the large and small vessels that supply the heart in a range of participants, as well as assess the function of the cells that line the blood vessels. We hope to enhance our knowledge in this area and develop new strategies to treat future patients with this under-recognized condition.

Interventions

Patients referred to the cardiac catheter laboratory are invited to participate in the study. Invasive physiology testing including fractional flow reserve and index of micro-circulatory resistance will be measured in all participants. Coronary pressure wires will be inserted into the coronary arteries via a guiding catheter, and measurements including pressure and mean saline transit time will be measured under both resting and hyperaemic conditions. Every 5th presenting patient will also hav

Patients referred to the cardiac catheter laboratory are invited to participate in the study. Invasive physiology testing including fractional flow reserve and index of micro-circulatory resistance will be measured in all participants. Coronary pressure wires will be inserted into the coronary arteries via a guiding catheter, and measurements including pressure and mean saline transit time will be measured under both resting and hyperaemic conditions. Every 5th presenting patient will also have endothelial function and wall shear stress assessed. Patients will be followed up to 5 years, and be assessed for recurrent chest pain, revascularization, myocardial infarction, and death.

Sponsors

Royal Prince Alfred Hospital (Sydney Local Health District)
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients referred to the cardiac catheter laboratory for coronary angiography or percutaneous coronary intervention

Exclusion criteria

Pregnancy, cardiogenic shock, contraindication to adenosine, severe asthma, heavily calcified or tortuous vessels leading to inability to advance pressure wire

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026